AddBIO AB

About:

AddBIO AB has developed Zolidd®, a proprietary bioactive nanoparticle for orthopedic and dental implants that liberates bisphosphonate.

Website: http://addbio.se/

Top Investors: Almi Invest

Description:

AddBIO AB has developed Zolidd®, a proprietary bioactive nanoparticle for orthopedic and dental implants that liberates bisphosphonate, a bone enhancement drug.

Total Funding Amount:

9.4M SEK

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Linköping, Ostergotlands Lan, Sweden

Founded Date:

2008-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2012-04-17

IPO Status:

Private

Industries: